Day: January 5, 2024

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates inclusive (the “Class Period”). A class action […]

CMI INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cummins Inc. Investors to Inquire About Securities Class Action Investigation – CMI

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cummins Inc. (NYSE: CMI) resulting from allegations that Cummins may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN […]

Back To Top